Prostate antineoplastic agents. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Prostate Cell Line, Tumor Tumor Cells, Cultured HL-60 Cells Cell Line Cells, Cultured Seminal Vesicles Epithelial Cells Rectum

Organisms7

Narcissus Mice, Nude Aster Plant Olacaceae Mice, SCID Mice, Inbred BALB C Mice, Inbred C57BL

Diseases30

Leukemia P388 Prostatic Neoplasms Neoplasms Sarcoma 180 Prostatic Hyperplasia Leukemia L1210 Neoplasms, Experimental Lung Neoplasms Breast Neoplasms Prostatic Intraepithelial Neoplasia Adenocarcinoma Ovarian Neoplasms Colonic Neoplasms Leukemia Neoplasms, Hormone-Dependent Bone Neoplasms Prostatic Diseases Disease Progression Neoplasm Metastasis Prostatitis Carcinoma Neoplasm Invasiveness Prostatic Neoplasms, Castration-Resistant Neovascularization, Pathologic Genetic Predisposition to Disease Phlebitis Disease Models, Animal Cell Transformation, Neoplastic Carcinoma, Ehrlich Tumor Neoplasm Recurrence, Local

Chemicals and Drugs101

Antineoplastic Agents Antineoplastic Agents, Phytogenic Amaryllidaceae Alkaloids Ellipticines Bibenzyls Doxorubicin Antibiotics, Antineoplastic Thiadiazines Bryostatins Antineoplastic Agents, Alkylating Ancitabine Prostate-Specific Antigen Gallium Depsipeptides Paclitaxel Cisplatin 6-Mercaptopurine Epothilones Aminoacridines Lactones Antimetabolites, Antineoplastic Daunorubicin Fluorouracil Androgens Receptors, Androgen Bleomycin Etoposide Prodrugs Androgen Antagonists Stilbenes Enzyme Inhibitors Macrolides Camptothecin Methotrexate RNA, Messenger Taxoids Vincristine Isoquinolines Caspases Cyclophosphamide DNA Tumor Markers, Biological Reactive Oxygen Species Dihydrotestosterone Phospholipid Ethers Tosyl Compounds Finasteride Antineoplastic Agents, Hormonal Androgen Receptor Antagonists Neoplasm Proteins 5-alpha Reductase Inhibitors Anilides Anticarcinogenic Agents Flutamide Testosterone Metribolone Sulindac DNA, Neoplasm Azasteroids Glutamate Carboxypeptidase II 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Cholestenone 5 alpha-Reductase Plant Extracts Testosterone Congeners RNA, Small Interfering PTEN Phosphohydrolase Androgen-Binding Protein Amsacrine Vanadium Compounds Azacitidine Thiosemicarbazones Prostatic Secretory Proteins Proto-Oncogene Proteins c-akt Hazardous Substances Suramin Proto-Oncogene Proteins c-bcl-2 Diphosphonates Racemases and Epimerases Antigens, Neoplasm 2-Propanol Floxuridine Transcription Factors Estramustine Glutathione Transferase Sulfonamides RNA, Neoplasm Anti-Inflammatory Agents, Non-Steroidal Androstenols Nitrogen Mustard Compounds Caspase 3 Mitoxantrone Topoisomerase II Inhibitors Phenylthiohydantoin Carmustine Cytarabine Histone Deacetylase Inhibitors Farnesyltranstransferase Drugs, Investigational DNA Adducts Dioxoles DNA-Binding Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment60

Drug Screening Assays, Antitumor Xenograft Model Antitumor Assays Antineoplastic Combined Chemotherapy Protocols Drug Evaluation, Preclinical Drug Evaluation Neoplasm Transplantation Prostatectomy Neoplasms, Experimental Transurethral Resection of Prostate Drug Administration Schedule Orchiectomy Clinical Trials as Topic Treatment Outcome Immunohistochemistry Digital Rectal Examination Gloves, Protective Transplantation, Heterologous Neoplasm Grading Reverse Transcriptase Polymerase Chain Reaction Blotting, Western Case-Control Studies Brachytherapy Neoplasm Staging Castration Risk Factors Biopsy, Needle Prognosis Protective Devices Transfection Biopsy Tumor Burden Tumor Stem Cell Assay Equipment and Supplies, Hospital Protective Clothing Inhibitory Concentration 50 Gene Expression Profiling Radiotherapy, Conformal Flow Cytometry Radiotherapy Sensitivity and Specificity Disease Models, Animal Retrospective Studies Antineoplastic Protocols Comet Assay Drug Compounding Cohort Studies Combined Modality Therapy Radiotherapy Planning, Computer-Assisted Radiotherapy, Intensity-Modulated Mass Screening Survival Analysis Early Detection of Cancer Models, Biological Radiotherapy Dosage Organ Size Incidence Polymerase Chain Reaction Radiotherapy, Image-Guided Nomograms Tissue Array Analysis

Phenomena and Processes40

Apoptosis Drug Synergism Cell Survival Molecular Structure Dose-Response Relationship, Drug Cell Division Cell Proliferation Drug Resistance, Neoplasm Cell Cycle Drug Resistance Time Factors Gene Expression Regulation, Neoplastic Biotransformation Drug Interactions DNA Damage Stereoisomerism Kinetics Structure-Activity Relationship Signal Transduction Cell Growth Processes Transfection Dental Physiological Processes Inhibitory Concentration 50 Down-Regulation Genetic Predisposition to Disease Up-Regulation Base Sequence Sensitivity and Specificity Promoter Regions, Genetic Cell Movement Phosphorylation Transcription, Genetic Gene Expression Drug Resistance, Multiple Tissue Distribution Organ Size Cell Death Gene Fusion DNA Adducts Nomograms

Disciplines and Occupations2

Immunohistochemistry Oncology Nursing

Technology, Industry, Agriculture4

Gloves, Protective Laundering Protective Devices Protective Clothing

Information Science6

Radiotherapy, Conformal Base Sequence Molecular Sequence Data Radiotherapy Planning, Computer-Assisted Radiotherapy, Intensity-Modulated Incidence

Named Groups3

Medical Secretaries Nursing Staff, Hospital Personnel, Hospital

Health Care23

Clinical Trials as Topic Treatment Outcome Occupational Exposure Case-Control Studies Watchful Waiting Oncology Nursing Risk Factors Medical Secretaries Equipment Contamination Decontamination Nursing Staff, Hospital Sensitivity and Specificity Environmental Monitoring Retrospective Studies Antineoplastic Protocols Personnel, Hospital Cohort Studies Mass Screening Survival Analysis Pharmacies Incidence Oncology Service, Hospital Nomograms

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Named Groups Health Care

Antineoplastic Agents Prostate Antineoplastic Agents, Phytogenic Leukemia P388 Amaryllidaceae Alkaloids Narcissus Ellipticines Bibenzyls Drug Screening Assays, Antitumor Doxorubicin Antibiotics, Antineoplastic Cell Line, Tumor Prostatic Neoplasms Thiadiazines Bryostatins Tumor Cells, Cultured Antineoplastic Agents, Alkylating Neoplasms Apoptosis Ancitabine Prostate-Specific Antigen Gallium Depsipeptides Paclitaxel Cisplatin Drug Synergism Cell Survival 6-Mercaptopurine Epothilones Aminoacridines Molecular Structure Sarcoma 180 Lactones Xenograft Model Antitumor Assays Dose-Response Relationship, Drug Cell Division Prostatic Hyperplasia Leukemia L1210 Mice, Nude Antimetabolites, Antineoplastic Cell Proliferation Daunorubicin Fluorouracil Drug Resistance, Neoplasm Antineoplastic Combined Chemotherapy Protocols Androgens Receptors, Androgen Bleomycin Etoposide Prodrugs Drug Evaluation, Preclinical Drug Evaluation Cell Cycle Neoplasm Transplantation Prostatectomy Neoplasms, Experimental Androgen Antagonists Drug Resistance Stilbenes Enzyme Inhibitors Macrolides Camptothecin Methotrexate Time Factors Lung Neoplasms Transurethral Resection of Prostate Drug Administration Schedule HL-60 Cells RNA, Messenger Breast Neoplasms Orchiectomy Taxoids Gene Expression Regulation, Neoplastic Prostatic Intraepithelial Neoplasia Adenocarcinoma Vincristine Isoquinolines Clinical Trials as Topic Biotransformation Drug Interactions Cell Line DNA Damage Stereoisomerism Caspases Cyclophosphamide Ovarian Neoplasms Kinetics Colonic Neoplasms Leukemia Neoplasms, Hormone-Dependent Treatment Outcome DNA Tumor Markers, Biological Structure-Activity Relationship Bone Neoplasms Cells, Cultured Prostatic Diseases Reactive Oxygen Species Dihydrotestosterone Disease Progression

No FAQ available that match "prostate antineoplastic agents"